Nigel Killeen
Consultor / Asesor en Julz Co. Llc .
Perfil
Nigel Killeen was the founder of Austrianni GmbH, which was founded in 2014, where he held the title of Chief Scientific Officer.
Currently, he is a Senior Advisor at Julz Co. LLC since 2015.
Previously, he worked as the Chief Scientific Officer at Trianni, Inc. from 2010 to 2015.
Mr. Killeen has a doctorate from the University of Oxford and an undergraduate degree from the University of Toronto.
Cargos activos de Nigel Killeen
| Empresas | Cargo | Inicio |
|---|---|---|
Julz Co. Llc
 Julz Co. Llc Investment ManagersFinance Julz Co LLC (Julz) is a venture capital firm founded in 2016. The firm is headquartered in Chapel Hill, North Carolina. | Consultor / Asesor | 01/01/2015 |
Antiguos cargos conocidos de Nigel Killeen.
| Empresas | Cargo | Fin |
|---|---|---|
Trianni, Inc.
 Trianni, Inc. BiotechnologyHealth Technology TRIANNI, Inc. operates as a biotech company. It specializes in antibody discovery technology using transgenic mice. Its Trianni Mouse platform enables the generation of fully-human monoclonal antibodies. The company was founded in 2010 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 02/01/2015 |
| Austrianni GmbH | Fundador | 01/01/2015 |
Formación de Nigel Killeen.
| University of Toronto | Undergraduate Degree |
| University of Oxford | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Julz Co. Llc
Julz Co. Llc Investment ManagersFinance Julz Co LLC (Julz) is a venture capital firm founded in 2016. The firm is headquartered in Chapel Hill, North Carolina. | Finance |
Trianni, Inc.
Trianni, Inc. BiotechnologyHealth Technology TRIANNI, Inc. operates as a biotech company. It specializes in antibody discovery technology using transgenic mice. Its Trianni Mouse platform enables the generation of fully-human monoclonal antibodies. The company was founded in 2010 and is headquartered in San Francisco, CA. | Health Technology |
| Austrianni GmbH |
- Bolsa de valores
- Insiders
- Nigel Killeen
